Latest news
Loading news…
Engage Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Carlos, California, United States Founded 2021 1-10 employees For Profit
Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications.
Engage Bio was acquired by Eli Lilly in 2026 for $202M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 33
- IT spend
- $214K
Company Info
- Founded
- 2021
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 11
- HQ
- San Carlos, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Exit date
- May 20, 2026
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -1.5
- Trend (30d)
- -4.4
- Trend (90d)
- 7.2
7
professional contacts at Engage Bio
Contact execs at Engage Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Engage Bio
Loading news…
FAQs about Engage Bio
People who checked this page also checked these
Browse the full Acquirezy directory.